Beverly Long
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Beverly Long has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Amy Weaver
Mayo Clinic, Department of Biostatistics, United States of America
1 shared publication- Anna BuAbbud
George Washington University Hospital, Department of Obstetrics and Gynecology, 900 23rd ST NW, Washington, DC 20037, United States
1 shared publication - Annie Coriolan Ciceron
School of Nursing, The George Washington University, Washington, DC 20006, USA
1 shared publication - Chunling Hu
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
1 shared publication - Daisy Le
Department of Prevention and Community Health, Milken Institute School of Public Health, Washington, USA
1 shared publication - Emma A. Keegan
George Washington University, School of Medicine and Health Sciences, 2300 I St NW, Washington, DC 20052, United States
1 shared publication
Latest Publications
- Open Access
- 26 January 2022
- Published by MDPI AG in Current Oncology
- Vol. 29 (2) , 516-533
Cervical Cancer Prevention and High-Risk HPV Self-Sampling Awareness and Acceptability among Women Living with HIV: A Qualitative Investigation from the Patients’ and Providers’ Perspectives
Routine cervical cancer screening is important for women living with HIV (WLH) due to the greater incidence and persistence of high-risk HPV (HR-HPV) infection. HR-HPV self-sampling has been proposed to overcome barriers to in-office cervical cancer screening in underserved populations. However, little is known about baseline knowledge of HR-HPV and the acceptability of HR-HPV self-sampling among WLH. This paper describes WLH’s experiences and needs regarding cervical cancer screening, specifically HR-HPV self-sampling, and seeks to reconcile their experiences with the views of their providers. In total, 10 providers and 39 WLH participated in semi-structured interviews and group discussions, respectively. Knowledge of cervical cancer and HR-HPV was generally limited among WLH; when present, it was often due to personal experience of or proximity to someone affected by cervical cancer. Most WLH were not familiar with HR-HPV self-sampling but, despite some of the providers’ skepticism, expressed their willingness to participate in a mail-based HR-HPV self-sampling intervention and highlighted convenience, ease of use, and affordability as facilitators to the uptake of HR-HPV self-sampling. The experiences identified can be used to guide patient-centered communication aimed at improving cervical cancer knowledge and to inform interventions, such as HR-HPV self-sampling, designed to increase cervical cancer screening among under-screened WLH.
- 26 January 2022
- Published by MDPI AG in Current Oncology
- Vol. 29 (2) , 516-533
Open AccessCervical Cancer Prevention and High-Risk HPV Self-Sampling Awareness and Acceptability among Women Living with HIV: A Qualitative Investigation from the Patients’ and Providers’ Perspectives
Routine cervical cancer screening is important for women living with HIV (WLH) due to the greater incidence and persistence of high-risk HPV (HR-HPV) infection. HR-HPV self-sampling has been proposed to overcome barriers to in-office cervical cancer screening in underserved populations. However, little is known about baseline knowledge of HR-HPV and the acceptability of HR-HPV self-sampling among WLH. This paper describes WLH’s experiences and needs regarding cervical cancer screening, specifically HR-HPV self-sampling, and seeks to reconcile their experiences with the views of their providers. In total, 10 providers and 39 WLH participated in semi-structured interviews and group discussions, respectively. Knowledge of cervical cancer and HR-HPV was generally limited among WLH; when present, it was often due to personal experience of or proximity to someone affected by cervical cancer. Most WLH were not familiar with HR-HPV self-sampling but, despite some of the providers’ skepticism, expressed their willingness to participate in a mail-based HR-HPV self-sampling intervention and highlighted convenience, ease of use, and affordability as facilitators to the uptake of HR-HPV self-sampling. The experiences identified can be used to guide patient-centered communication aimed at improving cervical cancer knowledge and to inform interventions, such as HR-HPV self-sampling, designed to increase cervical cancer screening among under-screened WLH.
- 1 January 2019
- Published by Elsevier in Gynecologic Oncology
- Vol. 152 (1) , 20-25
Cancer susceptibility gene mutations in type I and II endometrial cancer
- 1 January 2019
- Published by Elsevier in Gynecologic Oncology
- Vol. 152 (1) , 20-25
Cancer susceptibility gene mutations in type I and II endometrial cancer